Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Single nucleosome imaging reveals loose genome chromatin networks via active RNA polymerase II.

Nagashima R, Hibino K, Ashwin SS, Babokhov M, Fujishiro S, Imai R, Nozaki T, Tamura S, Tani T, Kimura H, Shribak M, Kanemaki MT, Sasai M, Maeshima K.

J Cell Biol. 2019 May 6;218(5):1511-1530. doi: 10.1083/jcb.201811090. Epub 2019 Mar 1.

2.

Unveiling epidithiodiketopiperazine as a non-histone arginine methyltransferase inhibitor by chemical protein methylome analyses.

Sohtome Y, Shimazu T, Barjau J, Fujishiro S, Akakabe M, Terayama N, Dodo K, Ito A, Yoshida M, Shinkai Y, Sodeoka M.

Chem Commun (Camb). 2018 Aug 14;54(66):9202-9205. doi: 10.1039/c8cc03907k.

PMID:
30063235
3.

MHC-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigs.

Mizukami Y, Abe T, Shibata H, Makimura Y, Fujishiro SH, Yanase K, Hishikawa S, Kobayashi E, Hanazono Y.

PLoS One. 2014 Jun 13;9(6):e98319. doi: 10.1371/journal.pone.0098319. eCollection 2014.

4.

DNA methylation profiles provide a viable index for porcine pluripotent stem cells.

Arai Y, Ohgane J, Fujishiro SH, Nakano K, Matsunari H, Watanabe M, Umeyama K, Azuma D, Uchida N, Sakamoto N, Makino T, Yagi S, Shiota K, Hanazono Y, Nagashima H.

Genesis. 2013 Nov;51(11):763-76. doi: 10.1002/dvg.22423. Epub 2013 Aug 30.

5.

Generating porcine chimeras using inner cell mass cells and parthenogenetic preimplantation embryos.

Nakano K, Watanabe M, Matsunari H, Matsuda T, Honda K, Maehara M, Kanai T, Hayashida G, Kobayashi M, Kuramoto M, Arai Y, Umeyama K, Fujishiro SH, Mizukami Y, Nagaya M, Hanazono Y, Nagashima H.

PLoS One. 2013 Apr 23;8(4):e61900. doi: 10.1371/journal.pone.0061900. Print 2013.

6.

Epidithiodiketopiperazine as a pharmacophore for protein lysine methyltransferase G9a inhibitors: reducing cytotoxicity by structural simplification.

Fujishiro S, Dodo K, Iwasa E, Teng Y, Sohtome Y, Hamashima Y, Ito A, Yoshida M, Sodeoka M.

Bioorg Med Chem Lett. 2013 Feb 1;23(3):733-6. doi: 10.1016/j.bmcl.2012.11.087. Epub 2012 Dec 5.

PMID:
23266120
7.

Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development.

Fujishiro SH, Nakano K, Mizukami Y, Azami T, Arai Y, Matsunari H, Ishino R, Nishimura T, Watanabe M, Abe T, Furukawa Y, Umeyama K, Yamanaka S, Ema M, Nagashima H, Hanazono Y.

Stem Cells Dev. 2013 Feb 1;22(3):473-82. doi: 10.1089/scd.2012.0173. Epub 2012 Oct 9.

8.

A Simplified In Vitro Teratoma Assay for Pluripotent Stem Cells Injected Into Rodent Fetal Organs.

Masuda S, Yokoo T, Sugimoto N, Doi M, Fujishiro SH, Takeuchi K, Kobayashi E, Hanazono Y.

Cell Med. 2012 May 8;3(1-3):103-112. doi: 10.3727/215517912X639351. eCollection 2012 Jan.

9.

Unnatural enantiomer of chaetocin shows strong apoptosis-inducing activity through caspase-8/caspase-3 activation.

Teng Y, Iuchi K, Iwasa E, Fujishiro S, Hamashima Y, Dodo K, Sodeoka M.

Bioorg Med Chem Lett. 2010 Sep 1;20(17):5085-8. doi: 10.1016/j.bmcl.2010.07.032. Epub 2010 Jul 13.

PMID:
20675131
10.

Total synthesis of (+)-chaetocin and its analogues: their histone methyltransferase G9a inhibitory activity.

Iwasa E, Hamashima Y, Fujishiro S, Higuchi E, Ito A, Yoshida M, Sodeoka M.

J Am Chem Soc. 2010 Mar 31;132(12):4078-9. doi: 10.1021/ja101280p.

PMID:
20210309
11.

ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA.

Fujishiro SH, Tanimura S, Mure S, Kashimoto Y, Watanabe K, Kohno M.

Biochem Biophys Res Commun. 2008 Mar 28;368(1):162-7. doi: 10.1016/j.bbrc.2008.01.066. Epub 2008 Jan 22.

PMID:
18211802
12.

n-3 long-chain FA decrease serum levels of TG and remnant-like particle-cholesterol in humans.

Hamazaki K, Itomura M, Huan M, Nishizawa H, Watanabe S, Hamazaki T, Sawazaki S, Terasawa K, Nakajima S, Terano T, Hata Y, Fujishiro S.

Lipids. 2003 Apr;38(4):353-8.

PMID:
12848279
13.

Specific blockade of the ERK pathway inhibits the invasiveness of tumor cells: down-regulation of matrix metalloproteinase-3/-9/-14 and CD44.

Tanimura S, Asato K, Fujishiro SH, Kohno M.

Biochem Biophys Res Commun. 2003 May 16;304(4):801-6.

PMID:
12727228
14.

Impact of boost irradiation with surgically placed radiopaque clips on local control in breast-conserving therapy.

Kokubo M, Mitsumori M, Yamamoto C, Fujishiro S, Mise K, Kodama H, Nagata Y, Hiraoka M.

Breast Cancer. 2001;8(3):222-8. Erratum in: Breast Cancer 2002;9(2):184.

PMID:
11668244
15.

A case of allergic reaction to surgical metal clips inserted for postoperative boost irradiation in a patient undergoing breast-conserving therapy.

Tamai K, Mitsumori M, Fujishiro S, Kokubo M, Ooya N, Nagata Y, Sasai K, Hiraoka M, Inamoto T.

Breast Cancer. 2001;8(1):90-2.

PMID:
11180773
16.

Meningeal carcinomatosis in patients with breast cancer: report of 8 patients.

Yu H, Mitsumori M, Nagata Y, Katakura Y, Kokubo M, Oya N, Fujishiro S, Sasai K, Hiraoka M, Kan N.

Breast Cancer. 2001;8(1):74-8.

PMID:
11180770
17.

Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiences.

Kokubo M, Mitsumori M, Ishikura S, Nagata Y, Fujishiro S, Inamoto T, Mise K, Kodama H, Sasai K, Hiraoka M.

Am J Clin Oncol. 2000 Oct;23(5):499-505.

PMID:
11039512
18.

Determination of optimal radiation energy for different breast sizes using CT-simulator [correction of simulatior] in tangential breast irradiation.

Nihei K, Mitsumori M, Ishigaki T, Fujishiro S, Kokubo M, Nagata Y, Sasai K, Hiraoka M.

Breast Cancer. 2000;7(3):231-6.

PMID:
11029803
19.

Cosmetic results and complications after breast conserving therapy for early breast cancer.

Fujishiro S, Mitsumori M, Kokubo M, Nagata Y, Sasai K, Mise K, Kodama H, Hiroka M.

Breast Cancer. 2000 Jan;7(1):57-63.

PMID:
11029772
20.

Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases.

Terano T, Fujishiro S, Ban T, Yamamoto K, Tanaka T, Noguchi Y, Tamura Y, Yazawa K, Hirayama T.

Lipids. 1999;34 Suppl:S345-6. No abstract available.

PMID:
10419198
21.

Gallstone ileus with impaction at the neck of a Meckel's diverticulum.

Nakamoto Y, Saga T, Fujishiro S, Washida M, Churiki M, Matsuda K.

Br J Radiol. 1998 Dec;71(852):1320-2.

PMID:
10319010
22.

Increased heating efficiency of hyperthermia using an ultrasound contrast agent: a phantom study.

Fujishiro S, Mitsumori M, Nishimura Y, Okuno Y, Nagata Y, Hiraoka M, Sano T, Marume T, Takayama N.

Int J Hyperthermia. 1998 Sep-Oct;14(5):495-502.

PMID:
9789772
23.

A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer.

Mitsumori M, Hiraoka M, Okuno Y, Nishimura Y, Li YP, Fujishiro S, Nagata Y, Abe M, Koishi M, Sano T, Marume T, Takayama N.

Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1169-75.

PMID:
8985040
24.

Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.

Kobayashi H, Shinohara H, Gotoh J, Fujie M, Fujishiro S, Terao T.

Br J Cancer. 1995 Nov;72(5):1131-7.

25.
26.

Biochemical markers as a predictor for lymph-node involvement in patients with cervical-cancer of the uterus.

Kobayashi H, Fujishiro S, Terao T.

Int J Oncol. 1994 May;4(5):1053-9.

PMID:
21567019
27.

[Urokinase-type plasminogen activator as a predictor for lymph nodes metastasis of uterine cervical cancer].

Fujishiro S, Kobayashi H, Terao T.

Nihon Sanka Fujinka Gakkai Zasshi. 1994 Feb;46(2):129-36. Japanese.

PMID:
8126385
28.

[The effect of granulocyte elastase inhibitor (urinastatin) vaginal suppository on patients with imminent premature delivery].

Kanayama N, Chinarong L, Naruse H, Yamamoto N, Fujishiro S, Maehara K, Morita Y, Terao T.

Nihon Sanka Fujinka Gakkai Zasshi. 1992 Apr;44(4):477-82. Japanese.

PMID:
1343816

Supplemental Content

Loading ...
Support Center